We are live on ! Find out more
Allspring Global Investments

Allspring Global Investments Portfolio holdings

AUM $65.2B
1-Year Est. Return 39.42%
This Fund
S&P 500
This Quarter Est. Return
+20.8%
1 Year Est. Return
+39.42%
3 Year Est. Return
+106.84%
5 Year Est. Return
10 Year Est. Return
AUM
$65.2B
AUM Growth
+$5.51B
Cap. Flow
-$1.61B
Cap. Flow %
-2.48%
Top 10 Hldgs %
15.6%
Holding
1,978
New
223
Increased
860
Reduced
686
Closed
104

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$406M
2
MSFT icon
Microsoft
MSFT
+$339M
3
ON icon
ON Semiconductor
ON
+$311M
4
GPK icon
Graphic Packaging
GPK
+$182M
5
BAH icon
Booz Allen Hamilton
BAH
+$156M

Sector Composition

Rank Sector Weight
1 Technology 24.46%
2 Industrials 15.56%
3 Financials 10.17%
4 Healthcare 9.84%
5 Consumer Discretionary 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBS icon
1601
Sabesp
SBS
$15.8B
$266K ﹤0.01%
+46,259
New +$280K
NOV icon
1602
NOV
NOV
$7.55B
$265K ﹤0.01%
14,713
+873
+6% +$17.4K
ADMA icon
1603
ADMA Biologics
ADMA
$2.1B
$265K ﹤0.01%
30,771
-448,808
-94% -$4.09M
REPX icon
1604
Riley Exploration Permian
REPX
$801M
$262K ﹤0.01%
+8,103
New +$289K
EQNR icon
1605
Equinor
EQNR
$97.1B
$261K ﹤0.01%
8,379
+608
+8% +$22.7K
KURA icon
1606
Kura Oncology
KURA
$950M
$261K ﹤0.01%
24,187
+890
+4% +$8.4K
CIBR icon
1607
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.7B
$260K ﹤0.01%
2,870
PKX icon
1608
POSCO
PKX
$17.8B
$258K ﹤0.01%
5,151
+1,358
+36% +$93.1K
NBTB icon
1609
NBT Bancorp
NBTB
$2.79B
$253K ﹤0.01%
5,081
+63
+1% +$2.88K
CGON icon
1610
CG Oncology
CGON
$6.68B
$252K ﹤0.01%
+3,553
New +$232K
NVAX icon
1611
Novavax
NVAX
$1.31B
$252K ﹤0.01%
+26,613
New +$238K
GMAB icon
1612
Genmab
GMAB
$19.6B
$250K ﹤0.01%
9,047
-70
-0.8% -$1.86K
GFS icon
1613
GlobalFoundries
GFS
$29.4B
$249K ﹤0.01%
+3,224
New +$225K
VYGR icon
1614
Voyager Therapeutics
VYGR
$197M
$249K ﹤0.01%
71,050
+2,220
+3% +$8.42K
FOX icon
1615
Fox Class B
FOX
$25.4B
$248K ﹤0.01%
5,127
-231
-4% -$12.8K
BBD icon
1616
Banco Bradesco
BBD
$33.7B
$247K ﹤0.01%
71,058
-962,529
-93% -$3.52M
GRAL
1617
GRAIL Inc
GRAL
$3.05B
$247K ﹤0.01%
+3,623
New +$213K
PAC icon
1618
Grupo Aeroportuario del Pacifico
PAC
$12.2B
$246K ﹤0.01%
+973
New +$239K
ZEPP
1619
Zepp Health
ZEPP
$81.4M
$244K ﹤0.01%
46,748
VIPS icon
1620
Vipshop
VIPS
$6.78B
$243K ﹤0.01%
17,906
+3,056
+21% +$43.7K
DIN icon
1621
Dine Brands
DIN
$443M
$242K ﹤0.01%
+6,741
New +$201K
TAP icon
1622
Molson Coors Class B
TAP
$7.92B
$242K ﹤0.01%
6,200
-4,599
-43% -$192K
RKLB icon
1623
Rocket Lab Corp
RKLB
$51.3B
$241K ﹤0.01%
+2,413
New +$240K
NHI icon
1624
National Health Investors
NHI
$3.59B
$239K ﹤0.01%
3,135
+359
+13% +$27.5K
IXN icon
1625
iShares Global Tech ETF
IXN
$9.41B
$238K ﹤0.01%
+1,740
New +$224K

Similar funds

Allspring Global Investments's Q2 2026 Portfolio in Review

As of Q2 2026, Allspring Global Investments held 1,978 positions worth $65.2B, up 9.2% from $59.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Allspring Global Investments's Q2 2026 filing shows 223 new, 860 increased, 686 reduced and 104 closed positions. Its largest new stake was MACOM Technology Solutions: 362,062 shares worth $127M. The largest sale was Teradyne, an estimated $406M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Allspring Global Investments's largest Q2 2026 buy was MACOM Technology Solutions: 362,062 shares worth $127M.
  • Allspring Global Investments added most to Apple in Q2 2026, an estimated $419M increase.
  • Allspring Global Investments's biggest Q2 2026 reduction was Teradyne, cutting an estimated $406M.
  • Allspring Global Investments fully exited Guidewire Software in Q2 2026, selling an estimated $51.4M.
  • Allspring Global Investments's ten largest holdings make up 16% of its $65.2B portfolio in Q2 2026.
  • Allspring Global Investments opened 223 new positions and closed 104 in Q2 2026.
  • Allspring Global Investments's portfolio value rose 9.2% quarter-over-quarter to $65.2B.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.